Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experiences with percutaneous endoscopic gastrostomy

C N Gutt1, S Held, V Paolucci

  • 1Department of General Surgery, Johann-Wolfgang-Goethe University, D-60590 Frankfurt, Germany.

World Journal of Surgery
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: a biomarker analysis from the NEOLAP trial (AIO-PAK-0113).

ESMO gastrointestinal oncology·2026
Same author

[Software-supported analysis of geriatric discharge letters : Potential of technology-driven data analysis in quality and discharge management at the transition to outpatient care].

Zeitschrift fur Gerontologie und Geriatrie·2025
Same author

Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].

ESMO open·2024
Same author

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

ESMO open·2024
Same author

Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial.

ESMO open·2024
Same author

Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).

ESMO open·2024
Same journal

Prediction Models for Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer: Validation of Existing Nomograms, Model Development, and Ensemble Evaluation.

World journal of surgery·2026
Same journal

Indicators for Monitoring Recovery From Surgery to Discharge Using Accelerometer in Patients With Esophageal Cancer.

World journal of surgery·2026
Same journal

The Safety of In-Hospital Delay and the Utility of dNLR in Elderly Patients With Acute Appendicitis.

World journal of surgery·2026
Same journal

Feasibility of Post-Operative Telehealth for Pediatric Surgical Patients in Malawi-A Mixed Methods Analysis.

World journal of surgery·2026
Same journal

Surgical Infrastructure and Workforce Readiness in Rwanda's District and Level 2 Teaching Hospitals: A Nationwide Facility-Based Survey.

World journal of surgery·2026
Same journal

From General Preparedness to Injury-Pattern-Specific Trauma Resource Planning.

World journal of surgery·2026
See all related articles

Percutaneous endoscopic gastrostomy (PEG) is a safe and effective method for long-term enteral feeding, offering a simpler alternative to surgical gastrostomy with low complication rates and improved patient tolerance.

Area of Science:

  • Gastroenterology
  • Endoscopic Procedures

Background:

  • Percutaneous endoscopic gastrostomy (PEG) is the preferred method for long-term enteral feeding in patients with swallowing difficulties.
  • Indications include head and neck cancers, neurologic dysphagia, and esophageal obstruction.

Purpose of the Study:

  • To evaluate the efficacy and safety of the pull-technique for PEG placement.
  • To assess complication rates and patient outcomes.

Main Methods:

  • The pull-technique using 15-Freka PEG tubes was used in 115 patients.
  • Procedure time averaged 17 minutes, including esophagogastroduodenoscopy.
  • Single-shot antibiotic prophylaxis was administered.

Main Results:

  • PEG insertion was successful in 106 out of 115 patients.

Related Experiment Videos

  • 40% of patients experienced mild abdominal pain post-procedure.
  • Only one serious complication (presumed perforation) occurred, requiring no surgical intervention.

    • Conclusions:

    • PEG is a safe and effective alternative to surgical gastrostomy.
    • The procedure is associated with low complication rates, short hospital stays, and good patient tolerance.
    • It is a cost-efficient option for long-term enteral nutrition.